Stay updated with breaking news from Bioscience Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Auckland based Douglas Pharmaceuticals has signed a license agreement with U.S based Daré Bioscience, Inc to develop and commercialise R-131-2, a novel topical medicinal candidate for the treatment for cervical intraepithelial neoplasia. Managing Director ...
Scoop Auckland provides news and views from Auckland, New Zealand
Researchers working to bring a sustainable source of omega-3 oil to market have reached a significant milestone in achieving scaled-up production of a genetically modified camelina seed oil.
/PRNewswire/ -- The blood market size is expected to grow by USD 2,195.69 million from 2022 to 2027. In addition, the momentum of the market will progress at a...
Daré Bioscience, Inc. (NASDAQ:DARE – Get Free Report)’s stock price passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.92 and traded as low as $0.62. Daré Bioscience shares last traded at $0.63, with a volume of 280,238 shares trading hands. […]